SMTL ID : 8dg6.1

Scaffold Hopping via Ring Opening Enables Identification of Acyclic Compounds as New Complement Factor D Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x S7X: 1-{2-[(2S)-2-{[(3-chloro-2-fluorophenyl)methyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}-1H-indazole-3-carboxamide(Non-covalent)

S7X.1: 20 residues within 4Å: Chain A: H.24, L.25, C.26, H.41, W.128, G.129, I.130, R.137, S.178, C.179, K.180, G.181, S.183, V.197, T.198, S.199, G.200, S.201, R.202, C.204 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.25, A:I.130, A:R.137, A:K.180, A:K.180, A:K.180, A:R.202 Hydrogen bonds: A:L.25, A:G.181, A:S.183, A:T.198, A:R.202 Water bridges: A:S.178, A:S.178 Halogen bonds: A:W.128

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, W. et al., Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors. Bioorg.Med.Chem. (2022)

Release Date

2022-11-02

Peptides

Complement factor D: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Complement factor D

Related Entries With Identical Sequence